Intravenous Ferric carboxy maltose in the treatment of severe iron deficiency anaemia patients
- Conditions
- Health Condition 1: D508- Other iron deficiency anemias
- Registration Number
- CTRI/2022/12/048152
- Lead Sponsor
- Subhashree Kar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Age 18 years and above of either sex.
2.All diagnosed patients of severe IDA, attending Clinical Haematology & Medicine Department of SCB Medical College and Hospital, Cuttack.
3.TSAT Levels less than 30%
4.He/She must be willing to comply to study protocol till the end of the trial.
5.He/She is willing to give written informed consent at the baseline visit.
6.All patients will be provided with patient information sheet regarding all pros and cons of the study at the baseline visit.
1.Age <18 years
2.Pregnant and Lactating women
3.Anemia due to any other cause other than IDA
4.Patients with known history of hypersensitivity to iv Iron injection
5.Patients with iron treatment or blood transfusion within 4weeks prior to treatment
6.Patients with recent history of treatment with Erythropoetin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method